These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 910606

  • 1. [Recent progress in the treatment of Hodgkin's disease].
    Jacquillat C.
    Acquis Med Recent; 1977; ():89-98. PubMed ID: 910606
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M, Teillet F, Weisgerber C, Dana M, Jacquillat C, Bernard J.
    Rev Prat; 1974 Oct 11; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract] [Full Text] [Related]

  • 3. The treatment of Hodgkin's disease.
    Fairley GH.
    Trans Med Soc Lond; 1972 Oct 11; 88():61-71. PubMed ID: 4665820
    [No Abstract] [Full Text] [Related]

  • 4. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E, Kende G, Many A, Ramot B.
    Harefuah; 1974 Apr 01; 86(7):348-51. PubMed ID: 4846045
    [No Abstract] [Full Text] [Related]

  • 5. Letter: Chemotherapy of Hodgkin's disease.
    Winokur SH.
    N Engl J Med; 1974 Dec 12; 291(24):1309. PubMed ID: 4431438
    [No Abstract] [Full Text] [Related]

  • 6. ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.
    Clamon GH, Corder MP.
    Cancer Treat Rep; 1978 Mar 12; 62(3):363-7. PubMed ID: 77188
    [No Abstract] [Full Text] [Related]

  • 7. [Drug therapy of Hodgkin's disease].
    Gallmeier WM, Bruntsch U.
    Internist (Berl); 1981 May 12; 22(5):289-300. PubMed ID: 7019138
    [No Abstract] [Full Text] [Related]

  • 8. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM, Casassus P, Coscas Y, Darmont J, Goubeau C, Katz M, Jacquillat C, Tricot G, Weil M.
    Bull Cancer; 1982 May 12; 69(4):321-9. PubMed ID: 6897520
    [No Abstract] [Full Text] [Related]

  • 9. [Chemotherapy of Hodgkin's disease].
    Amiel JL, Mathé G.
    Rev Prat; 1974 Oct 11; 24(45):3957-60, 3963-4, 3967-8. PubMed ID: 4141118
    [No Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    McElwain TJ, Wrigley PF, Hunter A, Crowther D, Malpas JS, Peckham MJ, Smithers DW, Fairley GH.
    Natl Cancer Inst Monogr; 1973 May 11; 36():395-402. PubMed ID: 4744597
    [No Abstract] [Full Text] [Related]

  • 11. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
    Lopez M.
    Clin Ter; 2001 May 11; 152(3):203-6. PubMed ID: 11692542
    [No Abstract] [Full Text] [Related]

  • 12. Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Prosnitz LR, Farber LR, Fischer JJ, Bertino JR.
    Radiology; 1973 Apr 11; 107(1):187-93. PubMed ID: 4689429
    [No Abstract] [Full Text] [Related]

  • 13. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
    DeVita VT.
    Natl Cancer Inst Monogr; 1973 May 11; 36():373-9. PubMed ID: 4744596
    [No Abstract] [Full Text] [Related]

  • 14. Combination chemotherapy of advanced Hodgkin's disease. A review.
    Goldsmith MA, Carter SK.
    Cancer; 1974 Jan 11; 33(1):1-8. PubMed ID: 4129559
    [No Abstract] [Full Text] [Related]

  • 15. [Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
    Babini L, Sciascia R, Baccarani M, Emiliani E, Fiacchini M, Franchini A, Lauria F, Tura S.
    Radiol Med; 1978 Feb 11; 64(2):113-8. PubMed ID: 684251
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of Hodgkin's disease].
    Brule G.
    Arq Patol; 1974 Feb 11; 46(2-3):273-7. PubMed ID: 4458640
    [No Abstract] [Full Text] [Related]

  • 17. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
    Baillet F, Brun B, Mazeron JJ, Rochant H, Pinon G, Reyes F, Vernant JP, Pierquin B, Dreyfus B.
    Nouv Rev Fr Hematol Blood Cells; 1977 Feb 11; 18(2):457-61. PubMed ID: 917834
    [Abstract] [Full Text] [Related]

  • 18. Greater curability in advanced Hodgkin's disease?
    Portlock CS.
    Cancer J Sci Am; 1999 Feb 11; 5(5):264-5. PubMed ID: 10526665
    [No Abstract] [Full Text] [Related]

  • 19. Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up).
    Jacquillat C, Weil M, Auclerc G, Desprez-Curely JP, Chastang C, Garçon C, Chantalou JP, Gemon-Auclerc MF, Delobel J, Dana M, Tanzer J, Teillet F, Izrael V, Chelloul N, Weisgerber C, De Heaulme M, Boiron M, Bernard J.
    Eur J Cancer (1965); 1975 Oct 11; 11(10):679-88. PubMed ID: 1204663
    [No Abstract] [Full Text] [Related]

  • 20. [Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
    Lauria F, Baccarani M, Barbieri E, Fiacchini M, Gobbi M, Tura S, Baccarani M.
    Haematologica; 1975 Mar 11; 60(1):73-84. PubMed ID: 806500
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.